Results 321 to 330 of about 2,411,306 (333)

Biomarker Changes during 20 Years Preceding Alzheimer's Disease.

New England Journal of Medicine
BACKGROUND Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer's disease have not been extensively investigated in longitudinal studies.
J. Jia, Yuye Ning, Meilin Chen, Shuheng Wang, Hao Yang, Fangyu Li, Jiayi Ding, Yan Li, Bote Zhao, Jihui Lyu, Shanshan Yang, Xin Yan, Yue Wang, W. Qin, Qi Wang, Ying Li, Jintao Zhang, Furu Liang, Z. Liao, Shan Wang   +19 more
semanticscholar   +1 more source

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
D. Doroshow, S. Bhalla, M. Beasley, L. Sholl, K. Kerr, S. Gnjatic, I. Wistuba, D. Rimm, M. Tsao, F. Hirsch   +9 more
semanticscholar   +1 more source

Biomarker-based staging of Alzheimer disease: rationale and clinical applications

Nature Reviews Neurology
J. Therriault, S. Schindler, Gemma Salvadó, T. Pascoal, A. Benedet, N. Ashton, T. Karikari, L. Apostolova, M. Murray, I. Verberk, Jacob W. Vogel, R. La Joie, S. Gauthier, C. Teunissen, G. Rabinovici, H. Zetterberg, Randall J. Bateman, P. Scheltens, K. Blennow, R. Sperling, Oskar Hansson, Clifford R. Jack, P. Rosa-Neto   +22 more
semanticscholar   +1 more source